A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma

Journal of Experimental Medicine

Volumn 189, Issue 7, 1999, Pages 1101-1110

  Zhang, Jian Ying ^a   Chan, Edward K L ^a   Peng, Xuan Xian ^b   Tan, Eng M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b XIAMEN UNIVERSITY   (China)

Author keywords

Autoantibody; Cloning; Hepatocellular carcinoma; RNA binding motif; Tumor antigen

Indexed keywords

AUTOANTIGEN; CYTOPLASM PROTEIN; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; CELL FUNCTION; CELL TRANSFORMATION; DNA REPLICATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA BINDING; XENOPUS LAEVIS;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; BASE SEQUENCE; BINDING SITES; CARCINOMA, HEPATOCELLULAR; CONSENSUS SEQUENCE; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELA CELLS; HEPATITIS B; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER NEOPLASMS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; OPEN READING FRAMES; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR CELLS, CULTURED;

EID: 0033526101     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.7.1101     Document Type: Article

References (46)

1. Tan, E.M. 1991. Autoantibodies in pathology and cell biology. Cell. 67:841-842.
2. Tan, E.M. 1997. Autoantibodies and autoimmunity: a three-decade perspective. A tribute to Henry G. Kunkel. Ann. NY Acad. Sci. 815:1-14.
3. Miyachi, K., M.J. Fritzler, and E.M. Tan. 1978. Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. 121:2228-2234.
4. Bravo, R., R. Frank, P.A. Blundell, and H. Macdonald-Bravo. 1987. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature. 326:515-517.
5. Chan, E.K., H. Imai, J.C. Hamel, and E.M. Tan. 1991. Human autoantibody to RNA polymerase I transcription factor hUBF. Molecular identity of nucleolus organizer region autoantigen NOR-90 and ribosomal RNA transcription up-stream binding factor. J. Exp. Med. 174:1239-1244.
6. Gottlieb, E., and J.A. Steitz. 1989. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO (Eur. Mol. Biol. Organ.) J. 8:851-861.
7. Reimer, G., K.M. Rose, U. Scheer, and E.M. Tan. 1987. Autoantibody to RNA polymerase I in scleroderma sera. J. Clin. Invest. 79:65-72.
8. Lerner, M.R., and J.A. Steitz. 1979. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 76:5495-5497.
9. Moroi, Y., C. Peebles, M.J. Fritzler, and E.M. Tan. 1980. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl. Acad. Sci. USA. 77:1627-1631.
10. Brenner, S., D. Pepper, M.E. Berne, E.M. Tan, and B.R. Brinkley. 1981. Kinetochore structure, duplication, and distribution in mammalian cells: analysis by human autoantibodies from scleroderma patients. J. Cell Biol. 91:95-102.
11. Earnshaw, W.C., K.F. Sulllivan, P.S. Machlin, C.A. Coke, D.A. Kaiser, T.D. Pollard, N.F. Rothfield, and D.W. Cleveland. 1987. Molecular cloning of cDNA for CENP-B, the major human centromere. J. Cell Biol. 104:817-829.
12. Tan, E.M., E.K. Chan, K.F. Sullivan, and R.L. Rubin. 1988. Antinuclear antibodies (ANAs): Dignostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin. Immunol. Immunopathol. 47:121-141.
13. Tillman, D.M., N.-T. Jou, R.J. Hill, and T.N. Marion. 1992. Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB X NZW)F1 mice. J. Exp. Med. 176:761-779.
14. Radic, M.Z., and M. Weigert. 1994. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu. Rev. Immunol. 12:487-520.
15. Burnham, T.K. 1972. Antinuclear antibodies in patients with malignancies. Lancet. 2:2436-2437.
16. Steiner, M., E. Klein, and G. Klein. 1975. Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases. Clin. Immunol. Immunopathol. 4:374-381.
17. Thomas, P.J., J.S. Kaur, C.T. Aitcheson, W.A. Robinson, and E.M. Tan. 1983. Antinuclear, antinucleolar, and anticytoplasmic antibodies in patients with malignant melanoma. Cancer Res. 43:1372-1380.
18. Wasserman, J., U. Glas, and H. Blomgren. 1975. Autoantibodies in patients with carcinoma of the breast: Correlation with prognosis. Clin. Exp. Immunol. 19:417-422.
19. Pupa, S.M., S. Menard, S. Andreola, and M. Colnaghi. 1993. Antibody response against the c-erbB-2 oncoprotein in breast carcinoma patients. Cancer Res. 53:5864-5866.
20. Dalmau, J., F. Graus, M.K. Rosenblum, and J.B. Posner. 1991. Anti-Hu associated paraneoplasic encephalomyelitis/sensory neuropathy: a clinical study of 71 patients. Medicine. 71:59-72.
21. Buckanovich, R.J., and R.B. Darnell. 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell Biol. 17:3194-3201.
22. Covini, G., C.A. von Muhlen, S. Pacchetti, M. Colombo, E.K. Chan, and E.M. Tan. 1997. Diversity of antinuclear antibody responses in hepatocellular carcinoma. J. Hepatol. 26: 1255-1265.
23. Imai, H., R.L. Ochs, K. Kiyosawa, S. Furuta, R.M. Nakamura, and E.M. Tan. 1992. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Am. J. Pathol. 140:859-870.
24. Imai, H., Y. Nakano, K. Kiyosawa, and E.M. Tan. 1993. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer. 71:26-35.
25. Imai, H., E.K. Chan, K. Kiyosawa, X.D. Fu, and E.M. Tan. 1993. Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J. Clin. Invest. 92:2419-2426.
26. Muro, Y., E.K. Chan, G. Landberg, and E.M. Tan. 1995. A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. Biochem. Biophys. Res. Commun. 207:1029-1037.
27. Winter, S.F., J.D. Minna, B.E. Johnson, T. Takahashi, A.F. Gazdar, and D.P. Carbone. 1992. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Cancer Res. 52:4168-4174.
28. Houghton, A.N. 1994. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180:1-4.
29. Sahin, U., Ö. Türeci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA. 92:11810-11813.
30. Old, L.J., and Y.-T. Chen. 1998. New paths in human cancer serology. J. Exp. Med. 187:1163-1167.
31. Zhang, J.Y., M. Dai, X. Wang, W.Q. Lu, D.S. Li, M.X. Zhang, K.J. Wang, L.P. Dai, S.G. Han, Y.F. Zhou, et al. 1998. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Int. J. Epidemiol. 27:574-578.
32. Chan, E.K., and K.M. Pollard. 1992. Autoantibodies to ribonucleoprotein particles by immunoblotting. In Manual of Clinical Laboratory Immunology. N.R. Rose, E. Conway de Macario, J.L. Fahey, H. Friedman, and G.M. Penn, editors. American Society for Microbiology, Washington, DC. 755-761.
33. Covini, G., E.K. Chan, M. Colombo, and E.M. Tan. 1996. Comparison of protocols for depleting anti-E. coli antibody in immunoblotting of recombinant antigens. J. Immunol. Methods. 190:143-145.
34. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
35. Huang, X. 1994. On global sequence alignment. Comput. Appl. Biosci. 10:227-235.
36. Pfeffer, U., E. Fecarotta, and G. Vidali. 1995. Efficient one-tube RT-PCR amplification of rare transcripts using short sequence-specific reverse transcription primers. Biotechniques. 18:204-206.
37. Rubin, R.L. 1986. Enzyme-linked immunosorbent assay for anti-DNA and anti-histone antibodies. In Manual of Clinical Laboratory Immunology. N.R. Rose, H. Friedman, and J.L. Fahey, editors. American Society for Microbiology, Washington, DC. 744-748.
38. Burd, C.G., and G. Dreyfuss. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science. 265: 615-621.
39. Muller-Pillasch, F., U. Lacher, C. Wallrapp, A. Micha, F. Zimmerhackl, H. Hameister, G. Varga, H. Friess, M. Buchler, H. Gunther Beger, et al. 1997. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene. 14:2729-2733.
40. Ross, A.F., Y. Oleynikov, E.H. Kislauskis, K.L. Taneja, and R.H. Singer. 1997. Characterization of a β-actin mRNA zipcode-binding protein. Mol. Cell Biol. 17:2158-2165.
41. Pfaff, S.L., and W.L. Taylor. 1992. Characterization of a Xenopus oocyte factor that binds to a developmentally regulated cis-element in the TFIIIA gene. Dev. Biol. 151:306-316.
42. Verkerk, A.J., M. Pieretti, J.S. Sutcliffe, Y.H. Fu, D.P.A. Kuhl, A. Pizzuti, O. Reiner, S. Richards, M.F. Victoria, F. Zhang, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 65:905-914.
43. Siomi, H., M.J. Matunis, W.M. Michael, and G. Dreyfuss. 1993. The pre-mRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res. 21:1193-1198.
44. Hahm, K., G. Kim, C.W. Turck, and S.T. Smale. 1993. Isolation of a murine gene encoding a nucleic acid-binding protein with homology to hnRNP K. Nucleic Acids Res. 21: 3894.
45. Davidoff, A.M., J.D. Iglehart, and J.R. Marks. 1992. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. Natl. Acad. Sci. USA. 89:3439-3442.
46. Chen, Y.-T., A.O. Cüre, S. Tsang, E. Stockert, E. Jäger, A. Knuth, and L.J. Old. 1998. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA. 95:6919-6923.